A. Pathophysiology
- Normal serum concentration [Na+] = 138-142 mmol/L (mM)
- Key parameters in evaluating changes in serum [Na+]
- Serum [Na+]
- Overall body volume status (hypovolemic, euvolemic, hypervolemic)
- Serum osmolarity (Osm)
- Total body [Na+] levels
- An abnormal plasma sodium value is indicative of a disorder of water homeostasis
- Sodium (Na+) is a functionally impermeable solute (to cells)
- The [Na+] cannot be used to determine the direction of the abnormality in fluid status
- This is because the total body Na+ determines the patient's volume status
- Any abnormal serum [Na+] value may associated with high or low or normal volume
- Serum Osmolarity
- Osm=2x[Na+](mM) + (urea nitrogen [mg/dL]÷ 2.8) + (glucose [mg/dL]÷ 18)
- Normal Osm is ~280-290 mOsm
- An increase in serum [Na+] (hypernatremia) always predicts a hyperosmolar state
- Serum Na+ levels must be corrected for hyperglycemia (and highly elevated BUN)
- Classifying Hypernatremia
- With low total body Na+
- With normal total body Na+ (including diabetes insipidus, DI)
- Hypervolemia and hypernatremia (Na+ overload)
- All patients with hypernatremia are have hypertonic hyperosmolarity
B. Development of Hypernatremia [3]
- The body PRIMARILY maintains osmolarity
- Sensors in the hypothalamus
- Sensors in the kidney
- Development of hypernatremia can occur by:
- Inadequate intake of water
- Hypothalamic dysfunction: abnormal sensors, inadequate ADH production (central DI)
- Renal dysfunction: inability to sense ADH (nephrogenic DI), drug effects (such as lithium)
- Hypertonic sodium gain (usually iatrogenic)
- Majority of patients with hypernatremia are either very young or very old
C. Causes [2]
- Overview
- Net water loss (most common): pure water loss or hypotonic fluid loss
- Hypertonic sodium gain (less common): hypertonic saline, sodium bicarbonate
- Hypotonic fluid loss: renal, gastrointestinal, or cutaneous (burns, sweating)
- Dehydration
- Divide into Inadequate Fluid Intake and/or Fluid Losses
- Fluid losses - consider dermal and respiratory
- Iatrogenic - most often occurs during hospitalization, not prior to it [3]
- Majority of hospitalizated patients lacked access to adequate free water [3]
- Fluid losses from osmotic diuresis or diarrhea or seizures
- Diabetes Mellitus (DM)
- Initial Presentation (especially type 1 diabetes)
- Diabetic Ketoacidosis
- Diabetes Insipidus (DI)
- Neurogenic (central) DI - failure to make (adequate) antidiuretic hormone (ADH or vasopressin)
- Neurogenic DI - post-traumatic, tumors, cysts, TB, sarcoidosis, aneurysms, GBS
- Alcohol intake causes transient neurogenic DI
- Nephrogenic DI - failure of kidney to respond to ADH (congenital or acquired)
- Acquired nephrogenic DI - renal disease, hypercalcemia, hypokalemia, drugs
- Drugs - lithium, demeclocycline, foscarnet, methoxyflurane, amphotericin B, vasopressin
- Renal Failure (inability to filter Na+)
- Coma (disordered ADH regulation; absence of thirst mechanism)
- Hyperaldosteronism
- However, mineralocorticoid excess alone rarely causes hypernatremia
- Although total body sodium increases in this disease, volume is highly expanded
D. Symptoms
- Polyuria (to excrete Sodium and Volume)
- Polydipsia (to replace fluid losses)
- Change in mental status
- Severe hypernatremia leads to seizures
- Most patients with hypernatremia are older
- Overall mortality was 41% for all patients with hypernatremia [3]
E. Evaluation of Serum Sodium (Na+) With Hyperglycemia [4]
- High levels of glucose induce hyponatremia
- This is due primarily to extracellular shift of water since glucose is extracellular
- Laboratory results for serum Na+ levels with hyperglycemia should be adjusted to reflect these fluid shifts (which will reverse as glucose levels drop)
- Classically, adjustment of 1.6 meq/L decrease in Na+ for every 100mg/dL increase in serum glucose (above baseline 100mg/dL) was used
- However, likely that adjustment factor of 2.4meq/L is more appropriate
- For example, if serum glucose is 800mg/dL and reported serum Na+ is 132meq/L, then the corrected serum Na+ level is {(800-100)/100} x 2.4 + 132 = 149meq/L
- The corrected serum Na+ level reflects the true state of hypovolemia
F. Therapy [2]
- Calculate free water deficit
- Deficit = BW·[(Na-140)÷ 140] where BW= Body water
- BW = FF·Wt(Kg) where FF= fluid fraction, 0.6 for men, 0.5-0.45 for women, and elderly
- Change in serum [Na+] = infusate [Na+] - serum [Na+]/(total body water+1)
- Rapid corrections of water deficits can result in neurological problems
- Rapid correction can induce cerebral edema with seizures and brain herniation
- Rapid correction (1.0mEq/hr) should be reserved only for very acute hypernatremia
- Safe rate of reduction in [Na+] is 0.5mM/hr or about 10mM/day
- For chronic hypernatremia, no more than 50% of fluid/sodium deficit should be corrected in first 24 hours [5]
- Electrolytes should be monitored at least every 6 hours
- Infusate [Na+] and Extracellular Distribution
- 5% Dextrose in water (D5) 0mM Na+ 40% extracellular distribution
- 0.2% NaCl in D5 in water 34mM 55%
- 0.45% NaCl (1/2NS) 77mM 73%
- Ringer's Lactate (RL) 130mM 97%
- 0.9% NaCl (NS) 154mM 100%
- Choice of Infusate
- Most patients have both depletion of total body water AND salt
- This occurs in euvolemic and hypovolemic hypernatremia
- Correction of problem should begin with 1/2 NS (0.45% NaCl) ± D5
- Normal saline (0.9% NaCl) should not be used unless hypotension is present [2]
- If [Na+] are very high, then consider using 0.2% NS with D5
- For patients with pure water deficits, D5 should generally be used
- If potassium (K+) has been lost, then KCl should be added to the infusate
- For patients without intake, daily maintenance fluid requires ADDITIONAL ~1.5L per day
- Maintenance fluid is RL or D5-1/2NS + 20mEq/L K+ (potassium)
- Hypervolemic Hypernatremia
- Discontinue offending salt heavy agents
- Furosemide
- Dialysis as needed for renal failure
- Care should be taken to minimize hypertonic drug and parenteral nutrition solutions
- Treatment of Diabetes Insipidus
- Central DI - DDAVP (desmopressin) nasal spray
- Nephrogenic DI - thiaizides, amiloride, and prostaglandin inhibitors have some benefit
References
- Kumar S and Berl T. 1998. Lancet. 352(9123):220
- Adrogue HJ and Madias NE. 2000. NEJM. 342(20):1493
- Palevsky PM, Bhagrath R, Greenberg A. 1996. Ann Intern Med. 124(2):197
- Hillier TA, Abbott RD, Barrett EJ. 1999. Am J Med. 106(4):399
- Gullans SR and Verbalis JG. 1993. Annu Rev Med. 44:289